These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 22763962

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
    Guo S, Yang B, Liu H, Li Y, Li S, Ma L, Liu J, Guo W.
    J Cancer Res Ther; 2017; 13(4):689-692. PubMed ID: 28901315
    [Abstract] [Full Text] [Related]

  • 23. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
    Zheng S, Li R, Liang J, Wen Z, Huang X, Du X, Dong S, Zhu K, Chen X, Liu D, Wu J, Liu Y, Zou X, Wang Y, Li J, Zeng F, Feng L, Yang G, Jing C.
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
    [Abstract] [Full Text] [Related]

  • 24. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Czygier M, Szmitkowski M.
    Przegl Lek; 2007 Apr; 64(12):987-90. PubMed ID: 18595499
    [Abstract] [Full Text] [Related]

  • 25. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    Ye S, Sun X, Kang B, Wu F, Zheng Z, Xiang L, Lesénéchal M, Heskia F, Liang J, Yang H.
    BMC Cancer; 2020 Feb 21; 20(1):138. PubMed ID: 32085736
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Diagnostic Value of Albumin to Fibrinogen Ratio in Cervical Cancer.
    Huang L, Mo Z, Zhang L, Qin S, Qin S, Li S.
    Int J Biol Markers; 2020 Jun 21; 35(2):66-73. PubMed ID: 32389031
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
    Yang S, Cheng H, Huang Z, Wang X, Wan Y, Cai J, Wang Z.
    Dis Markers; 2015 Jun 21; 2015():506428. PubMed ID: 25873749
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
    Ji M, Na N, Lin S.
    Clin Lab; 2021 Feb 01; 67(2):. PubMed ID: 33616317
    [Abstract] [Full Text] [Related]

  • 34. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep 01; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2010 Sep 01; 67(12):1314-8. PubMed ID: 21591359
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.